Technical considerations for KRAS testing in colorectal cancer. The pathologist's point of view;Aspect technique de la détermination du statut KRAS dans le cancer colorectal et mise en place en France. Point de vue de l'anatomopathologiste.

Bulletin du cancer

Volumn 96 Suppl, Issue , 2009, Pages

  Bibeau, F ^a   Frugier, H ^a   Denouel, A ^a   Sabourin, J C ^a   Boissiere Michot, F ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; MONOCLONAL ANTIBODY; PANITUMUMAB;

ARTICLE; COLORECTAL TUMOR; DRUG ANTAGONISM; DRUG RESISTANCE; GENETICS; HUMAN; METHODOLOGY; MOLECULAR PATHOLOGY; MUTATION; ONCOGENE RAS; PATHOLOGY;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; GENES, RAS; HUMANS; MUTATION; PATHOLOGY, CLINICAL; PATHOLOGY, MOLECULAR; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 75549092238     PISSN: None     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2009.0993     Document Type: Article

References (0)